YZYBIO-B (02496) plans to offer a discount of approximately 14.86% for a total issuance of 35,592,400 domestic shares, with trading resuming on September 10.

YZYBIO-B (02496) announced that on August 30, 2026, the company entered into a share subscription agreement with the subscribers (Dr. Yuan Qian, Dr. Zhou Hongfeng, and Dr. Zhou Pengfei). The company conditionally agreed to allocate and issue a total of 35,592,400 domestic shares to the subscribers at a subscription price of RMB 2.43 per share, representing a discount of approximately 14.86% compared to the closing price of HK$ 3.30 per H-share as reported by the Stock Exchange on August 28, 2026 (the last trading day before the share subscription agreement date). The company has applied for the resumption of trading for H-shares starting from 9:00 AM on September 10, 2026. Upon completion, the net proceeds from the share subscription are expected to be approximately RMB 83 million, of which about 90% will be used to repurchase bank loans, and about 10% will be used for the group's general working capital and general corporate purposes.